comparemela.com
Home
Live Updates
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT : comparemela.com
Cellectis Presents Research Data on a Novel Immune-Evasive Universal CAR T-cell at ASGCT
NEW YORK, May 16, 2022 -- Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today will present its first... | May 16, 2022
Related Keywords
New York ,
United States ,
Paris ,
France General ,
France ,
North Carolina ,
Raleigh ,
American ,
Ashleyr Robinson ,
Margaret Gandolfo ,
Julien Valton ,
Arthur Stril ,
Pascalyne Wilson ,
Linkedin ,
Allogene Therapeutics Inc ,
Evasive Properties Using ,
American Society Of Cell ,
Waltere Washington Convention Center ,
Nasdaq ,
Cellectis The Company Euronext Growth ,
Youtube ,
Euronext Growth ,
American Society ,
Gene Therapy Annual Meeting ,
Natural Killer ,
Vice President Gene Therapy ,
Endowing Universal ,
Immune Evasive Properties Using ,
Nasdaq Global Market ,
Allogene Therapeutics ,
Senior Manager ,
Chief Business Officer ,
Lifesci Advisors ,
Cellectis Sa Stock Exchange ,
News ,
Information ,
Press Release ,
Few ,
Bay ,
022 ,
Cellectis ,
Biotechnology ,
Company ,
Sing ,
Its ,
Ioneering ,
Platform ,
O ,
Evelop ,
Fell ,
End ,
Gene ,
Oday ,
Hill ,
Present ,
Ts Alcls Fr0010425595 ,
comparemela.com © 2020. All Rights Reserved.